On December 6, 2022, CABIO Biotech (Wuhan) Co., Ltd (CABIO), a leading Chinese biotechnology company, took part in the three-day Food Ingredients Europe 2022 (Fi […]
…..to Commercialize Efgartigimod Across Europe and Israel Medison Pharma (“Medison”), a global pharma company focused on providing access to highly innovative therapies to patients in […]
Today, on the eve of the World Cancer Day, the European Commission is presenting Europe’s Beating Cancer Plan – a main priority in the area […]
Sandra Gallina, Director General of the European Commission’s Directorate General for Health and Food Safety, talks about the imminent roll-out of COVID-19 vaccines. The EU […]
The Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA) has started the third rolling review process, the evaluation of […]
The Commission has today adopted a Pharmaceutical Strategy for Europe to ensure patients have access to innovative and affordable medicines and to support the competitiveness, […]
Today, the European Commission is taking the first steps towards building the European Health Union announced by President von der Leyen in her State of […]
As a first step towards the adoption of a Pharmaceutical Strategy for Europe the Commission yesterday published a roadmap, inviting interested citizens and stakeholders to […]
As part of the revised long-term EU budget 2021-2027 package, the European Commission has proposed a budget of €118.2 billion for external action, with an […]
• Reduces infusion time to 2 hours from the conventional 3.5 hours for patients with relapsing or primary progressive multiple sclerosis • EMA approval based […]
Today, the European Commission adopted a comprehensive new Biodiversity Strategy to bring nature back into our lives and a Farm to Fork Strategy for a […]
Yesterday, President von der Leyen gave a speech at the European Parliament plenary debate on the new Multiannual Financial Framework, own resources and the Recovery […]
Today, the European Investment Bank signed a €50 million financing agreement with Israeli regenerative medicine company Pluristem – through its German subsidiary Pluristem GmbH – […]
Today, President Ursula von der Leyen gave a speech at the European Parliament plenary session on the EU’s coordinated action to fight the coronavirus pandemic […]
Copyright © 2023 | WordPress Theme by MH Themes
